Studying the catalytic mechanisms of mitochondrial enzymes can provide insights into the dysfunctional pathways in MELAS syndrome. By understanding how specific mutations affect enzyme function, researchers can develop targeted therapies to compensate for the impaired catalytic activity. For instance, enhancing the activity of alternative pathways or introducing synthetic catalysts might help restore normal cellular function.
